Table 1.
Frequency n/n (%) | |
---|---|
Indication for eradication treatment | |
In all MRSA carriers | 18/114 (16) |
In selected cases | 58/114 (51) |
Planned/expected hospital visits | 58/58 (100) |
Infections with MRSA | 42/58 (72) |
Occupational reason (e.g., healthcare worker) | 52/58 (90) |
Patients’ request | 10/58 (17) |
In none of the MRSA carriers | 1/114 (1) |
Unknown | 37/114 (32) |
Reasons to refrain from treatment * | |
Potential self-limiting nature of MRSA carriership | 57/96 ** (59) |
Unfamiliarity with the policy | 24/96 (25) |
Treatment burden for patients | 22/96 (23) |
Lack of recommendation in the GP guideline | 17/96 (18) |
Patients’ request | 17/96 (18) |
Absence of benefit for the patient | 11/96 (11) |
Sense of incompetence to guide a treatment | 10/96 (10) |
Absence of benefit for the society | 5/96 (5) |
Costs for the patient | 4/96 (4) |
Other *** | 19/96 (20) |
Other *** | 19/96 (20) |
Legend: Indications for MRSA eradication according to Dutch general practitioners and reasons not to initiate treatment or refer for treatment. * Multiple answers possible. ** Eighteen GPs who answered in the previous question that all MRSA carriers have an indication for eradication treatment were not asked for reasons to refrain from treatment. *** Other reasons mentioned in free text: not a task for the GP, assumption of no curation, never considered, patient in palliative setting. GP = general practitioner.